Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection-Reference-Cited by-同舟云学术

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection

Published:2015-07 Issue:4 Volume:92 Page:837-842
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Ahmed Kamran A.,Fulp William J.,Berglund Anders E.,Hoffe Sarah E.,Dilling Thomas J.^ORCID,Eschrich Steven A.,Shridhar Ravi,Torres-Roca Javier F.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference29 articles.

1. Liver resection for colorectal metastases;Fong;J Clin Oncol,1997

2. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. The international registry of lung metastases;Pastorino;J Thorac Cardiovasc Surg,1997

3. Solitary colorectal liver metastasis: Resection determines outcome;Aloia;Arch Surg,2006

4. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial;Patchell;JAMA,1998

5. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial;Andrews;Lancet,2004

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review;Journal of Gastrointestinal Oncology;2024-08

2. Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer;Radiotherapy and Oncology;2024-07

3. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy;Advances in Radiation Oncology;2024-06

4. Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma;Clinical and Translational Radiation Oncology;2023-11

5. A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma;2023-09-14